1-7 of 7
Xavier Badoux, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Combination Therapy with Ofatumumab and Lenalidomide in Patients with Relapsed Chronic Lymphocytic Leukemia (CLL): Results of a Phase II Trial

Alessandra Ferrajoli, MD, Susan O'Brien, MD, William G. Wierda, MD, PhD, Stefan Faderl, MD, Xavier Badoux, MD, Zeev Estrov, Ellen Schlette, MD, Susan C. Smith, BS, Ana B. Ayala, ADN, Lorenzo Falchi, MD, Steliana Calin, MD, Hagop M. Kantarjian, MD, Michael J Keating, MD
Journal: Blood
Blood (2011) 118 (21): 1788.
https://doi.org/10.1182/blood.V118.21.1788.1788
Published: 2011
Journal Articles

Retrospective Analysis of the Experience with Rituximab and Methylprednisone In Elderly Patients with CLL

Xavier Badoux, MD, Ali M Al-Ameri, Susan O'Brien, MD, William G. Wierda, MD, PhD, Jan A. Burger, MD, PhD, Stefan Faderl, MD, Zeev Estrov, MD, Susan Lerner, MS, BA, Michael J Keating, MD, Alessandra Ferrajoli, MD
Journal: Blood
Blood (2010) 116 (21): 4636.
https://doi.org/10.1182/blood.V116.21.4636.4636
Published: 2010
Journal Articles

Decitabine and Gemtuzumab Ozogamicin In Patients with Advanced Myelofibrosis

Ali Al-Ameri Al-Ameri, MD, Hagop Kantarjian, MD, Asifa Malik, MD, Xavier Badoux, MD, Michael Andreeff, MD, PhD, Alfonso Quintas-Cardama, MD, Gautam Borthakur, MD
Journal: Blood
Blood (2010) 116 (21): 5061.
https://doi.org/10.1182/blood.V116.21.5061.5061
Published: 2010
Journal Articles

Phase II Study of Dasatinib In Patients with Relapsed Chronic Lymphocytic Leukemia.

Ali M Al-Ameri, MD, Xavier Badoux, MD, Alessandra Ferrajoli, MD, William G. Wierda, MD, PhD, Luis Fayad, MD, Zeev Estrov, MD, Susan Bickel, RN, Michael J Keating, MD, Susan O'Brien
Journal: Blood
Blood (2010) 116 (21): 4488.
https://doi.org/10.1182/blood.V116.21.4488.4488
Published: 2010
Journal Articles

The Combination of Lenalidomide and Rituximab Induces Complete and Partial Responses In Patients with Relapsed and Refractory Chronic Lymphocytic Leukemia.

Alessandra Ferrajoli, MD, Xavier Badoux, MD, Susan O'Brien, William G. Wierda, MD, PhD, Stefan Faderl, MD, Zeev Estrov, MD, Manolo Pasia, BSN, Susan Lerner, MS, BA, Hagop Kantarjian, MD, Michael J Keating, MD
Journal: Blood
Blood (2010) 116 (21): 1395.
https://doi.org/10.1182/blood.V116.21.1395.1395
Published: 2010
Journal Articles

Infectious Events In Patients with Chronic Myeloid Leukemia Treated with Nilotinib as a Front Line Therapy and After Imatinib Failure

Ali M Al-Ameri, MD, Jorge E. Cortes, MD, Hagop Kantarjian, MD, Elizabeth Burton, Alfonso Quintas-Cardama, MD, Elias Jabbour, MD, Xavier Badoux, MD, Susan O'Brien, Gloria Mattiuzzi, MD
Journal: Blood
Blood (2010) 116 (21): 1233.
https://doi.org/10.1182/blood.V116.21.1233.1233
Published: 2010
Journal Articles

Combination of Ofatumumab and Lenalidomide In Patients with Relapsed Chronic Lymphocytic Leukemia: Initial Results of a Phase II Trial

Xavier Badoux, MD, Susan O'Brien, MD, William G. Wierda, MD, PhD, Stefan Faderl, MD, Zeev Estrov, MD, Kimberly Yerrow, BSN, Hagop M. Kantarjian, MD, Michael J Keating, MD, Alessandra Ferrajoli, MD
Journal: Blood
Blood (2010) 116 (21): 2464.
https://doi.org/10.1182/blood.V116.21.2464.2464
Published: 2010